top of page
Cytonics
Login to favorite a company
Developing diagnostics and therapeutics for osteoarthritis
Most Recent Valuation:
$66,560,000.00
Legal Name:
Founded:
State of HQ:
Cytonics Corp
2006
FL
Company Description
Employees:
[]
Funding Summary
Number of funding rounds
5
Total amount raised
$12,152,726
Round name | End date | Raised | Status | Type | Investment minimum | Valuation | Valuation Cap | Price per share |
|---|---|---|---|---|---|---|---|---|
Cytonics Preferred Stock 5 | 08/26/2024 | $938,436.09 | closed | Preferred Stock | $499 | $66,560,000 | 2.3 | |
Cytonics Preferred Stock 4 | 05/29/2024 | $3,705,913.52 | closed | Preferred Stock | $499 | $65,790,000 | 2.3 | |
Cytonics Corporation Preferred Stock 2 | 10/14/2022 | $2,848,738.00 | closed | Preferred Stock | $1,001 | $58,915,996 | ||
Cytonics Corporation Stock 2 | 04/30/2021 | $4,659,638.00 | closed | Preferred Stock | $1,000 | $46,190,000 | 2 | |
Cytonics Corporation Share 1 | closed |
See round history
Round history
Round name | Perk description | Perk level (dollars) | Perk level (days) |
|---|
Loading...
Early Bird Perk history
Company notes
Type | Round name | Date Added | Date Updated | Notes |
|---|
Loading...
Financials (up to prior 4 years)
Revenue
COGS
Gross margin | (%)
Taxes
SG&A, other
Net income
Cash/Equivalents
Accounts Receiv
Other Assets
Assets
Short term debt
Long term debt
Equity/other liabilities
Gross margin, Other Assets, and Equity/other liabilities are derived from the financial statements of the company reported to the SEC. Assets = Liabilities + Equity, and no equity accounts nor accounts payable are reported to the SEC, hence the possibility for that amount to be either equity or a liability.
bottom of page